USMLE Step 1Haematology and oncologyEP 06 of 14

Sickle cell disease pathophysiology: HbS to vaso-occlusion

How one amino acid change makes haemoglobin S polymerise when deoxygenated, what promotes sickling, and how the polymer causes haemolysis, vaso-occlusion and functional asplenia.

  • 5:26 video
  • 3 min read
  • 4 sources
  • Published 15 Nov 2026
Chapters (12)
By the end of this lesson

Explain how HbS polymerisation under deoxygenation causes sickling, haemolysis and vaso-occlusion, and the factors that promote it.

The short version

  1. Valine replaces glutamate at position 6 of β-globin (GAG → GTG), creating a hydrophobic sticky patch on haemoglobin S.
  2. Oxygenated HbS stays soluble; on deoxygenation it polymerises into long, stiff fibres that make the cell sickle and rigid.
  3. Hypoxia, acidosis, high CO₂, fever, more 2,3-BPG (2,3-DPG) and a high intracellular HbS concentration (dehydration) promote sickling; fetal haemoglobin protects.
  4. The polymer causes haemolysis, vaso-occlusion with bone marrow infarcts and pain crises, and functional asplenia.

Sickle cell disease pathophysiology: why the disease waits

A baby is well for his first months. Then, in the second half of his first year, his hands swell and he cries when they are touched. The mutation was there from conception, so why did it wait?

This lesson follows one amino acid change through sickling, haemolysis and vaso-occlusion, and covers what promotes each step. The chain to learn: valine patch, deoxygenation, polymer, rigid cell, then haemolysis and blockage.

The answer to the opening puzzle has two halves. Fetal haemoglobin, which a newborn carries, has no β chains and also interferes with polymerisation. The disease appears only as fetal haemoglobin falls, and then deoxygenation, acid, heat and a high HbS concentration can set off the polymer.[1][2]

The HbS mutation and polymerisation on deoxygenation

Adult haemoglobin A is a tetramer of two α chains and two β chains.[1]

In haemoglobin S, a single base change, GAG → GTG, puts valine in place of glutamate at position 6 of the β chain.[1][2]

That swaps a charged, hydrophilic residue for a hydrophobic one, leaving a sticky patch on the surface of the molecule.[1][2]

Nothing else about the molecule needs to change. The single substitution is enough to give each haemoglobin S molecule a surface that can bind its neighbours once the conditions allow it.[1][2]

While oxygenated, haemoglobin S stays soluble. On deoxygenation, the sticky patches bind neighbouring molecules, and HbS polymerises into long, stiff fibres.[1][2][3]

The fibres distort the cell into a sickle shape and make it rigid.[2][1]

At first this reverses when the cell is reoxygenated. Repeated cycles of polymerising and melting, however, damage the red cell membrane.[1][4]

This is why sickling is described as a cycle rather than a single event: each trip through low-oxygen tissue can polymerise the haemoglobin, and each return to oxygenated blood melts it again, at a cost to the membrane.[1][4]

What promotes sickling: oxygen, acid, heat and HbS concentration

More deoxygenation means more polymer. Hypoxia leaves less oxygen on haemoglobin. Acidosis, a high carbon dioxide level, fever and more 2,3-BPG (2,3-DPG) all lower oxygen affinity, so every one of them promotes sickling.[1][3]

The other lever is concentration. The more HbS inside the cell, the faster the polymer forms, so dehydration is a trigger.[1][3]

The polymers also disturb ion channels, so the cell loses cations and water. That raises the HbS concentration further: a vicious circle.[1][2]

Promoters of polymerisation and what protects
FactorDirectionReason from the lesson
HypoxiaMore polymerLess oxygen on haemoglobin
Acidosis, high CO₂, fever, more 2,3-BPGMore polymerLower oxygen affinity
Higher HbS concentration, dehydrationMore polymerPolymer forms faster
Fetal haemoglobin (raised by hydroxyurea)Less polymerInterferes with polymerisation

Fetal haemoglobin interferes with polymerisation, so more of it protects. That is why hydroxyurea, which raises it, helps.[1][2][3]

Damage 1: haemolysis

Polymerisation cuts red cell lifespan from about 120 days to somewhere between 10 and 30 days; sources differ on the exact figure. Destruction happens both outside vessels, by macrophages especially in the spleen (extravascular), and inside vessels (intravascular).[1][2]

Haemolysis is the first of three kinds of damage the polymer causes. The other two, vaso-occlusion and functional asplenia, follow below.

Worked example: how much shorter is the lifespan?
  1. Normal lifespan ≈ 120 days
  2. 10 ÷ 120 = 1/12 and 30 ÷ 120 = 1/4
  3. Sickled cells survive roughly one twelfth to one quarter as long as normal cells

Damage 2: vaso-occlusion and pain crises

Rigid cells snag in small vessels. Sickled cells, white cells and platelets also stick to the endothelium.[2][1]

Tissue downstream becomes ischaemic. Pain crises are often caused by bone marrow infarcts, and cold, fever, dehydration or overexertion can set them off.[1][2]

So the same polymer produces two different problems: cells that are destroyed too early, and cells that block small vessels and starve the tissue behind them of oxygen.[1][2]

Damage 3: the spleen and functional asplenia

Slow, low-oxygen flow in the spleen promotes sickling early, so children become functionally asplenic and prone to infection with encapsulated organisms.[1][2]

Putting the chain together

Valine for glutamate at position 6 of β-globin makes a sticky patch that polymerises on deoxygenation. Hypoxia, acidosis, fever and a high HbS concentration promote sickling, and fetal haemoglobin protects. The polymer then causes haemolysis, vaso-occlusion and functional asplenia.[1][2]

Apply the chain to three patients.

  • A teenager with sleep apnoea: nightly hypoxia, more polymer.
  • A child with fever and diarrhoea: dehydration, acid and heat, more polymer.
  • A child on hydroxyurea: more fetal haemoglobin, less polymer.

Practice question

Original · USMLE style
Your turnQB-MS-S1-HEME-006-01

A 17-year-old boy with sickle cell anaemia (HbSS) develops severe thigh and back pain after a hike at high altitude. He has no fever and is well hydrated. Pulse oximetry shows 89% on room air. Haemoglobin is 8.2 g/dL and the reticulocyte count is 11%.

Which of the following most directly promoted sickling in this patient?
Pick one option. Your answers stay on this device.

Common questions

What is the cause of sickle cell disease at the molecular level?

A single base change, GAG → GTG, replaces glutamate with valine at position 6 of the β chain of haemoglobin. The hydrophobic valine forms a sticky patch on the surface.

Why do babies with sickle cell disease not have symptoms at birth?

Fetal haemoglobin has no β chains and interferes with polymerisation, so a newborn is protected. Features emerge in the second half of the first year as fetal haemoglobin falls.

What triggers HbS polymerisation?

Deoxygenation. Hypoxia, acidosis, high CO₂, fever and more 2,3-BPG promote it, as does a high HbS concentration from dehydration.

How does hydroxyurea help in sickle cell disease?

Hydroxyurea raises fetal haemoglobin, which interferes with HbS polymerisation, so less polymer forms.

Why are children with sickle cell disease prone to infection?

Slow, low-oxygen flow in the spleen promotes early sickling, causing functional asplenia and a risk of infection with encapsulated organisms.

Transcript

Read the full narration, by chapter628 words

0:00A baby well for months, then painful swollen hands: why did it wait?

A baby is well for his first months. Then, in the second half of his first year, his hands swell and he cries when they are touched. The mutation was there from conception. Why did it wait? Today: how one amino acid change causes sickling, haemolysis and vaso-occlusion, and what promotes it. Adult haemoglobin A has two alpha chains and two

0:22Haemoglobin A, the one-base change (GAG to GTG) and why the newborn is protected

beta chains. In haemoglobin S, a single base change, GAG to GTG, puts valine in place of glutamate at position six of the beta chain. That swaps a charged residue for a hydrophobic one: a sticky patch on the surface. Fetal haemoglobin has no beta chains, so a newborn is protected, and the disease appears as fetal haemoglobin falls.

0:51Deoxygenation: HbS polymerises and the cell sickles

While oxygenated, haemoglobin S stays soluble. On deoxygenation, the sticky patches bind neighbouring molecules, and haemoglobin S polymerises into long, stiff fibres. The fibres distort the cell into a sickle shape and make it rigid. At first this reverses when the cell is reoxygenated, but repeated cycles of polymerising and melting damage the membrane.

1:17What promotes polymerisation: hypoxia, acidosis, CO2, fever, 2,3-BPG

More deoxygenation means more polymer. Hypoxia leaves less oxygen on haemoglobin, and acidosis, a high carbon dioxide, fever and more two three DPG all lower oxygen affinity, so every one of them promotes sickling.

1:35HbS concentration, dehydration, fetal haemoglobin and hydroxyurea

The other lever is concentration. The more haemoglobin S inside the cell, the faster the polymer forms, so dehydration is a trigger. And the polymers disturb ion channels, so the cell loses water, a vicious circle. Fetal haemoglobin interferes with polymerisation, so more of it protects. That is why hydroxyurea, which raises it, helps.

2:01Damage 1: haemolysis

Now the damage, in three parts. First, haemolysis. Polymerisation cuts red cell lifespan from about 120 days to somewhere between 10 and 30 days, and the destruction happens in the spleen and inside vessels. Second, vaso-occlusion.

2:19Damage 2: vaso-occlusion and pain crises

Rigid cells snag in small vessels, and sickled cells, white cells and platelets stick to the endothelium. Tissue downstream goes ischaemic, and bone marrow infarcts cause the pain crises, which cold, fever, dehydration or overexertion can set off. Third, the spleen.

2:40Damage 3: the spleen and functional asplenia

Slow, low-oxygen flow there promotes sickling early, so children become functionally asplenic, and prone to infection with encapsulated organisms.

2:53Predict the trigger

Now predict. A teenager with sleep apnoea: nightly hypoxia, more polymer. A child with fever and diarrhoea: dehydration, acid and heat, more polymer. A child on hydroxyurea: more fetal haemoglobin, less polymer. The chain: valine patch, deoxygenation, polymer, rigid cell, then haemolysis and blockage.

3:19Practice question

Your turn. A 17-year-old boy with sickle cell anaemia develops severe thigh and back pain after a hike at high altitude. He has no fever and is well hydrated. Pulse oximetry is 89% on room air, haemoglobin is 8.2, and reticulocytes are 11%. Which of the following most directly promoted sickling in this patient? A, increased deoxygenated haemoglobin S. B, a higher fetal haemoglobin content. C, coexisting alpha-thalassaemia trait. D, an increased red cell water content. E, respiratory alkalosis from overbreathing. Pause here and decide. B is out: fetal haemoglobin interferes with

4:08Wrong options struck, then the answer

polymerisation, so more of it would protect. C is out: alpha-thalassaemia lowers the haemoglobin S concentration in the cell, so it would also protect. D is out: more water dilutes haemoglobin S and slows polymer formation; dehydration is the trigger. E is out: alkalosis raises oxygen affinity, so there is less deoxyhaemoglobin; it is acidosis that promotes sickling. So the answer is A. At altitude the lower oxygen pressure leaves more haemoglobin S deoxygenated, and deoxygenated haemoglobin S is what polymerises.

4:52Recap and next lesson: primary haemostasis

Three things to keep. One: valine for glutamate at position six of beta globin makes a sticky patch that polymerises on deoxygenation. Two: hypoxia, acidosis, fever and a high haemoglobin S concentration promote sickling; fetal haemoglobin protects. Three: the polymer causes haemolysis, vaso-occlusion and functional asplenia. Next, primary haemostasis: platelet adhesion and aggregation.

Sources

Numbers in the text, e.g. [1], point here
  1. Sickle Cell Disease. Transfus Med Hemother. 2024. europepmc.org/article/PMC/PMC11452173
  2. Sickle cell disease: understanding pathophysiology. Front Pharmacol. 2025. europepmc.org/article/PMC/PMC12411783
  3. The role of nucleation in sickle cell pathophysiology. Ann Med Surg. 2025. europepmc.org/article/PMC/PMC11981452
  4. Sickle Cell Disease in Children and Adolescents. 2022. europepmc.org/article/PMC/PMC9569228

The hook is an invented teaching vignette. The question values are synthetic.

The practice question is original and its patient is synthetic. Every fact is checked against the sources above in independent accuracy reviews. Always follow your local guidelines and your own laboratory’s ranges.

Image credits. Illustrations: Servier Medical Art (smart.servier.com), CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/), adapted (recoloured, outlined, resized): baby, hand, capsule, spleen, neutrophil. NIAID NIH BioArt Source (bioart.niaid.nih.gov), public domain, adapted (recoloured, outlined, resized): schematic haemoglobin (item 469), red blood cell (442), lysed red blood cell (445), blood vessel (55), platelet (415), bone marrow (56). Thermometer icon by kehan (via bioicons.com), CC0. The haemoglobin diagrams, codons, polymer, sickle cells, oxygen-haemoglobin curve, lifespan bars, question card, pocket card and all handwriting are drawn in code (original). No AI-generated teaching images.

Corrections. None so far. Spotted an error? Email info@medservatory.com with the lesson code MS-S1-HEME-006.

For exam study only, not medical advice. Read the medical disclaimer.

  1. EP 01Microcytic anaemia: four causes, four iron fingerprints5:37
  2. EP 02Hepcidin: why iron falls in inflammation5:34
  3. EP 03B12 vs folate deficiency: MMA, homocysteine and the nerves5:23
  4. EP 04Intravascular vs extravascular haemolysis: site and labs5:27
  5. EP 05G6PD deficiency vs hereditary spherocytosis, by mechanism5:36
  6. EP 06Sickle cell disease pathophysiology: HbS to vaso-occlusion5:26
  7. EP 07Primary haemostasis: platelet adhesion, activation and aggregation5:53
  8. EP 08Coagulation cascade: PT vs aPTT, pathway by pathway5:21
  9. EP 09Von Willebrand disease vs haemophilia: the labs that separate them5:32
  10. EP 10Anticoagulants: target, monitoring test and reversal agent5:34
  11. EP 11Heparin-induced thrombocytopenia: why a low count clots5:29
  12. EP 12DIC vs TTP vs HUS: mechanism and the PT/PTT5:33
  13. EP 13AML vs ALL vs CML vs CLL: leukemia classification made simple5:44
  14. EP 14Oncogenes vs tumour suppressor genes: one hit or two5:17